CDK9 inhibition as a potential therapeutic strategy in Ewing sarcoma

被引：0
|
作者：
Matsumura, Yuta
Heinz, Richard E.
Allred, Curtis A.
Siddiqui, Adam
Foulks, Jason M.
Warner, Steven L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5984
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5984
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting CDK9: a promising therapeutic opportunity in prostate cancer
    Rahaman, Muhammed H.
    Kumarasiri, Malika
    Mekonnen, Laychiluh B.
    Yu, Mingfeng
    Diab, Sarah
    Albrecht, Hugo
    Milne, Robert W.
    Wang, Shudong
    ENDOCRINE-RELATED CANCER, 2016, 23 (12) : T211 - T226
  • [22] Glycogen, a potential therapeutic target for Ewing Sarcoma
    Liu, Yueying
    Young, Lyndsay
    Singh, Pankaj
    Clarke, Harrison
    Hawkinson, Tara
    McCall, Meagan
    Sun, Ramon
    Gentry, Matthew
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S412 - S413
  • [23] MERTK Is a Potential Therapeutic Target in Ewing Sarcoma
    Smart, Sherri K.
    Yeung, Tsz Y.
    Santos, M. Olivia
    McSwain, Leon F.
    Wang, Xiaodong
    Frye, Stephen V.
    Earp III, H. Shelton
    DeRyckere, Deborah
    Graham, Douglas K.
    CANCERS, 2024, 16 (16)
  • [24] MERTK is a potential therapeutic target in Ewing sarcoma
    Smart, Sherri K.
    Yeung, Tsz Y.
    Wang, Xiaodong
    Frye, Stephen V.
    Earp, H. Shelton
    Graham, Douglas K.
    DeRyckere, Deborah
    CANCER RESEARCH, 2022, 82 (12)
  • [25] Addressing Transcriptional Dysregulation in Cancer through CDK9 Inhibition
    Toure, Mohammed A.
    Koehler, Angela N.
    BIOCHEMISTRY, 2023, 62 (06) : 1114 - 1123
  • [26] Selective inhibition of CDK9 in triple negative breast cancer
    Mustafa, Ebtihal H.
    Laven-Law, Geraldine
    Kikhtyak, Zoya
    Nguyen, Van
    Ali, Simak
    Pace, Alex A.
    Iggo, Richard
    Kebede, Alemwork
    Noll, Ben
    Wang, Shudong
    Winter, Jean M.
    Dwyer, Amy R.
    Tilley, Wayne D.
    Hickey, Theresa E.
    ONCOGENE, 2024, 43 (03) : 202 - 215
  • [27] The impact of combined CDK9 inhibition and TRAIL treatment on NSCLC
    Zubiaur, Itziar Areso
    Montinaro, Antonella
    von Karstedt, Silvia
    Lemke, Johannes
    Hartwig, Torsten
    Taraborelli, Lucia
    Surinova, Silvia
    El-Bahrawy, Mona A.
    Walczak, Henning
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [28] Selective inhibition of CDK9 in triple negative breast cancer
    Ebtihal H. Mustafa
    Geraldine Laven-Law
    Zoya Kikhtyak
    Van Nguyen
    Simak Ali
    Alex A. Pace
    Richard Iggo
    Alemwork Kebede
    Ben Noll
    Shudong Wang
    Jean M. Winter
    Amy R. Dwyer
    Wayne D. Tilley
    Theresa E. Hickey
    Oncogene, 2024, 43 : 202 - 215
  • [29] Inhibition of CDK2 affects CDK9 and inhibits HIV-1
    Breuer, Denitra
    Kotelkin, Alexander
    Ammosova, Tatyana
    Rotimi, Jamie
    Roane, Philip
    Gordeuk, Victor R.
    Nekhai, Sergei
    FASEB JOURNAL, 2011, 25
  • [30] Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
    Moreno, Natalia
    Holsten, Till
    Mertins, Julius
    Zhogbi, Annabelle
    Johann, Pascal
    Kool, Marcel
    Meisterernst, Michael
    Kerl, Kornelius
    ONCOTARGET, 2017, 8 (49) : 84986 - 84995
12345